Combination Therapy with Gossypol Reveals Synergism against Gemcitabine Resistance in Cancer Cells with High BCL-2 Expression

Open Access

Peer-reviewed

Research Article

Foong Ying Wong ,

* E-mail: wf_ying@hotmail.com

Affiliation Department of Haematology-Oncology, National University Health System, Singapore, Singapore
⨯
Natalia Liem,

Affiliation Department of Haematology-Oncology, National University Health System, Singapore, Singapore
⨯
Chen Xie,

Affiliation Department of Haematology-Oncology, National University Health System, Singapore, Singapore
⨯
Fui Leng Yan,

Affiliation Department of Haematology-Oncology, National University Health System, Singapore, Singapore
⨯
Wing Cheong Wong,

Affiliation Bioinformatics Institute, Agency for Science, Technology and Research, Singapore, Singapore
⨯
Lingzhi Wang,

Affiliation Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
⨯
Wei-Peng Yong

Affiliations Department of Haematology-Oncology, National University Health System, Singapore, Singapore, Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
⨯

Reader Comments (0)

Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Nasopharyngeal carcinoma
Is the Subject Area "Nasopharyngeal carcinoma" applicable to this article?

Thanks for your feedback.
Gastric cancer
Is the Subject Area "Gastric cancer" applicable to this article?

Thanks for your feedback.
Drug interactions
Is the Subject Area "Drug interactions" applicable to this article?

Thanks for your feedback.